Alerts will be sent to your verified email
Verify EmailLASA
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Lasa Supergenerics Limited, established in 2016 in Ratnagiri, Maharashtra, specializes in the manufacturing of API bulk drugs products.
Lasa Supergenerics major competitors are Mangalam Drugs&Org., Smruthi Organics, Tyche Inds, Bal Pharma, SMS Lifesciences, Everest Organics, Nectar Lifesciences.
Market Cap of Lasa Supergenerics is ₹84 Crs.
While the median market cap of its peers are ₹153 Crs.
Lasa Supergenerics seems to be less financially stable compared to its competitors.
Altman Z score of Lasa Supergenerics is 1.79 and is ranked 8 out of its 8 competitors.
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
Earnings Release | Mar Jun | Dec | Sep Dec | |||||||||||||||
Investor Presentation | Mar Jun Sep | Mar | Dec | |||||||||||||||
Conference Call | Mar | Mar Dec | Mar | Sep Dec | ||||||||||||||
Conference Call SummaryCon Call Summary
Powered by Gemini
|